The Maudsley Prescribing Guidelines in Psychiatry, 14th Edition

De (autor)
Notă GoodReads:
en Limba Engleză Paperback – 17 Jun 2021

The Maudsley® Prescribing Guidelines in Psychiatry

The new edition of the world-renowned reference guide on the use of medications for patients presenting with mental health problems

The Maudsley Prescribing Guidelines in Psychiatry is the essential evidence-based handbook on the safe and effective prescribing of psychotropic agents. Covering both common and complex prescribing situations encountered in day-to-day clinical practice, this comprehensive resource provides expert guidance on drug choice, minimum and maximum doses, adverse effects, switching medications, prescribing for special patient groups, and more. Each clear and concise chapter includes an up-to-date reference list providing easy access to the evidence on which the guidance is based.

The fourteenth edition has been fully updated to incorporate the latest available research, the most recent psychotropic drug introductions, and all psychotropic drugs currently used in the UK, USA, Canada, Australia, New Zealand, and Japan. Several new sections cover topics such as deprescribing of major psychiatric drugs, prescribing psychotropics at the end of life, the treatment of agitated delirium, the genetics of clozapine prescribing, the use of weekly penfluridol, and the treatment of psychotropic withdrawal. Featuring contributions by an experienced team of psychiatrists and specialist pharmacists, the new edition of The Maudsley Prescribing Guidelines in Psychiatry:

  • Provides succinct coverage of drug treatment of psychiatric conditions and formulating prescribing policy in mental health
  • Covers a wide range of psychiatric conditions including schizophrenia, bipolar disorder, depression and anxiety, borderline personality, eating disorders, and many others
  • Provides advice on prescribing for children and adolescents, older people, pregnant women, and other special patient groups
  • Offers new sections on genetic prescribing, long-acting injectable formulations, ketamine administration and uses, and dopamine super-sensitivity
  • Includes referenced information on off-label prescribing, potential interactions with other substances such as alcohol, tobacco, and caffeine, and treating patients with comorbid physical conditions

Whether in the doctor’s office, in the clinic, or on the ward, The Maudsley Prescribing Guidelines in Psychiatry, Fourteenth Edition is a must-have for psychiatrists, pharmacists, neuropharmacologists, clinical psychologists, nurses, and other healthcare professionals working in mental health, as well as trainees and students in medicine, pharmacy, and nursing.

Citește tot Restrânge

Preț: 31378 lei

Preț vechi: 32019 lei

Puncte Express: 471

Preț estimativ în valută:
6040 5893$ 5274£

Carte în stoc

Livrare din stoc 04 octombrie

Preluare comenzi: 021 569.72.76


ISBN-13: 9781119772224
ISBN-10: 1119772222
Pagini: 976
Dimensiuni: 179 x 239 x 34 mm
Greutate: 1.2 kg
Ediția: 14th Edition
Editura: Wiley
Locul publicării: Chichester, United Kingdom

Notă biografică

David Taylor, BSc, MSc, PhD, FFRPS, FRPharmS, FRCP (Edin) Director of Pharmacy and Pathology, Maudsley Hospital and Professor of Psychopharmacology, King's College, London, UK. Thomas R. E. Barnes, MBBS, MD, FRCPsych, DSc is Emeritus Professor of Clinical Pschiatry at Imperial College London and joint head of the Prescribing Observatory for Mental Health at the Royal College of Psychiatrists' Centre for Quality Improvement, London, UK. Allan H. Young, MB, ChB, MPhil, PhD, FRCPC, FRCPsych is Chair of Mood Disorders and Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King's College, London, UK.


Preface xi Acknowledgments xii Notes on using The Maudsley Prescribing Guidelines in Psychiatry xiii List of abbreviations xv Part 1 Drug treatment of major psychiatric conditions 1 Chapter 1 Schizophrenia and related psychoses 3 ANTIPSYCHOTIC DRUGS 3 ANTIPSYCHOTIC ADVERSE EFFECTS 109 REFRACTORY SCHIZOPHRENIA AND CLOZAPINE 190 CLOZAPINE ADVERSE EFFECTS 212 Chapter 2 Bipolar disorder 247 Chapter 3 Depression and anxiety disorders 305 Chapter 4 Addictions and substance misuse 451 Part 2 Drug treatment of special patient groups 537 Chapter 5 Children and adolescents 539 Chapter 6 Prescribing in older people 601 Chapter 7 Pregnancy and breastfeeding 679 Chapter 8 Hepatic and renal impairment 723 Part 3 Prescribing in specialist conditions 755 Chapter 9 Drug treatment of other psychiatric conditions 757 Chapter 10 Drug treatment of psychiatric symptoms occurring in the context of other disorders 777 Part 4 Other aspects of psychotropic drug use 831 Chapter 11 Pharmacokinetics 833 Chapter 12 Other substances 865 Chapter 13 Psychotropic drugs in special conditions 875 Chapter 14 Miscellany 897 Index 943